role of glp 1 GLP-1R and Diabetes Glucagon-Like Peptide-1 Receptor Agonists And

Multiple randomised, placebo-controlled trials have tested GLP-1 drugs as add-on therapy to insulin in people with T1D, and the picture that emerges is consistent, if modest: meaningful weight loss, real reductions in daily insulin needs, and improvements in CGM time in range

A 2025 systematic review in Clinical, Cosmetic and Investigational Dermatology examined 11 clinical studies on exosome therapy for hair loss

Cost-Effectiveness Analysis: Cost per Pound Lost (Estimated): Oral Semaglutide (Rybelsus): Average weight loss: 10 pounds (for 250 lb person) Cost: $900-$1,000/month for 6 months = $5,400-$6,000 Cost per pound lost: $540-$600 Injectable Semaglutide (Compounded from TrimRx): Average weight loss: 37 pounds (for 250 lb person) Cost: $199/month for 16 months = $3,184 Cost per pound lost: $86 Injectable Tirzepatide (Compounded from TrimRx): Average weight loss: 56 pounds (for 250 lb person) Cost: $349/month for 18 months = $6,282 Cost per pound lost: $112 Value Comparison: Hidden Costs: Oral Semaglutide: No injection supplies needed (saves $20-30/month) May require acid reflux medication if SNAC causes irritation Potential need for additional weight loss interventions if not effective Injectable Medications: Injection supplies usually included or inexpensive Sharps container ($5-10 one-time) Potential anti-nausea medication ($10-30/month if needed) Insurance Variables: If your insurance covers Rybelsus with a $25-$50 copay, it may seem like an attractive option

The development of oral formulations, such as oral semaglutide, has been a notable advancement in improving treatment acceptance

These statements are predictions based on speculative assumptions and are not guarantees of future performance

Both companies have faced FDA scrutiny